JunB deficiency leads to the development of acute and chronic myeloid leukemia, distant metastasis in breast cancer, and enhanced angiogenesis in prostate cancer by modulating the activity of various immune cells, such as promoting pro-angiogenic factor production by neutrophils. This evidence concerns the gene JUNB and chronic myelogenous leukemia, BCR-ABL1 positive.